Therapeutic Vaccine Strategies against Human Papillomavirus

Therapeutic Vaccine Strategies against Human Papillomavirus

High-risk types of human papillomavirus (HPV) cause over 500,000 cervical, anogenital and oropharyngeal cancer cases per year. The transforming potential of HPVs is mediated by viral oncoproteins. These are essential for the induction and maintenance of the malignant phenotype. Thus, HPV-mediated ma...

Full description

Bibliographic Details
Main Authors: Hadeel Khallouf, Agnieszka K. Grabowska, Angelika B. Riemer
Format: Article
Language:English
Published: MDPI AG 2014-06-01
Series:Vaccines
Subjects:
human papillomavirus (HPV)
therapeutic vaccination
cancer immunotherapy
epitopes
cytotoxic T cells (CTL)
T helper cells (Th)
cervical cancer
peptide vaccination
nanoparticles (NPs)
DNA vaccination
dendritic cell (DC) vaccination
vector-based vaccination
adjuvants
Online Access:http://www.mdpi.com/2076-393X/2/2/422

Internet

http://www.mdpi.com/2076-393X/2/2/422

Similar Items